Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

NIDA award supports Ensysce's development of opioid overdose protection platform

Sep. 19, 2018

NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder

Sep. 13, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Addicted to bile acids

Aug. 2, 2018

First cohort dosed in phase I study of OMS-527

July 18, 2018

The locus of alcohol's reward

June 29, 2018

Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527

June 28, 2018

DSMB of Aladote phase Ib/IIa study to treat paracetamol poisoning finds no safety concerns

June 25, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...